Related Experiment Videos

Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene

M Hewison1, A R Rut, K Kristjansson

  • 1Department of Medicine, UCL Medical School, London, UK.

Clinical Endocrinology
|December 1, 1993
PubMed
Abstract

Insights

Hereditary vitamin D resistant rickets (HVDRR) in a patient was linked to defective nuclear localization of the vitamin D receptor (VDR), not a VDR gene mutation. This finding reveals a new cause of VDR resistance.

Area of Science:

  • Endocrinology
  • Genetics
  • Molecular Biology

Background:

  • Hereditary vitamin D resistant rickets (HVDRR) presents with severe rickets and alopecia.
  • Mutations in the vitamin D receptor (VDR) gene are a known cause of HVDRR.
  • Investigating a patient with characteristic HVDRR to identify the functional defect and genetic cause.

Observation:

  • The patient exhibited rickets and alopecia, consistent with HVDRR.
  • Patient-derived cells showed normal binding of 1,25(OH)2D3 to the VDR.
  • However, VDR failed to localize to the nucleus, resulting in a lack of functional response.

Findings:

  • Sequencing revealed no mutations in the VDR coding region.
  • Functional studies demonstrated that the patient's VDR, when expressed, was functionally normal in transactivation assays.
  • The primary defect identified was the defective nuclear localization of the VDR.

Implications:

  • Identifies a novel mechanism of 1,25(OH)2D3 tissue resistance.
  • Highlights defective VDR nuclear localization as a cause of HVDRR, independent of VDR gene mutations.
  • Suggests potential for targeted therapies addressing VDR transport or localization in specific cases of rickets.

Related Concept Videos